4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001628280-25-000807
Chief Discovery/Trans Medicine sold 32,729 shares at an average $19.82 ($648,824)
- Chief Discovery/Trans Medicine acquired 100,000 shares (grant or award)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hamilton James C Chief Discovery/Trans Medicine | 2025-01-04 | Grant or award 10b5-1 | +100,000 | 304,851 | D: show line 1 in the form | ||
| Hamilton James C Chief Discovery/Trans Medicine | 2025-01-06 | Sale 10b5-1 | −21,758 | $19.68 | $428,197 | 283,093 | D: show line 2 in the form |
| Hamilton James C Chief Discovery/Trans Medicine | 2025-01-06 | Sale 10b5-1 | −10,971 | $20.11 | $220,627 | 272,122 | D: show line 3 in the form |
| Open-market sales · 32,729 sh · avg $19.82 · $648,824 | |||||||
Loading xslF345X05/wk-form4_1736303292.xml…